
Revlimid Coupons & Discount Card – Guaranteed Prices from $7407.03
lenalidomide
My prescription
Edit
10MG, Lenalidomide (30 Capsules)
Select pharmacy

Walgreens
$7407.03
COUPON PRICE
Rite Aid
$19948.40
COUPON PRICERevlimid savings card
Show this card to your pharmacist
Walgreens
$7407.03
BIN
ID
PCN
GRP
019876
LHC2CA2EFB
CHIPPO
LHX
Powered by
Related thalidomides prescriptions
More prescriptions for multiple myeloma
Related thalidomides prescriptions
More prescriptions for multiple myeloma
Revlimid dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
5MG | 30 Capsules | $7407.03 | $246.9 |
10MG | 30 Capsules | $7407.03 | $246.9 |
15MG | 30 Capsules | $7407.04 | $246.9 |
25MG | 30 Capsules | $7407.04 | $246.9 |
2.5MG | 30 Capsules | $7407.03 | $246.9 |
20MG | 30 Capsules | $7407.04 | $246.9 |
Revlimid Warnings
Lenalidomide, known as Revlimid, is a medication with significant safety considerations due to its potential risks. Below are key safety and warning points that should be carefully reviewed:
Pregnancy Risks: Lenalidomide is highly teratogenic and can cause severe birth defects or death to an unborn baby. Women of childbearing potential must use two forms of effective contraception for at least four weeks before, during, and for four weeks after treatment. Regular pregnancy tests are mandatory before starting and throughout the treatment period. If pregnancy occurs, discontinue the drug immediately and contact your healthcare provider.
REMS Program Compliance: In the US, lenalidomide is only available through the REMS program due to its risks. This program ensures that patients, prescribers, and pharmacies adhere to strict guidelines to prevent fetal exposure. If you are in another country, consult local regulations with your healthcare provider.
Blood Clot Risk: Lenalidomide may increase the risk of blood clots, especially in patients with a history of clots, high cholesterol, hypertension, or those who smoke. The risk is also elevated when used with estrogen-containing products or dexamethasone. Inform your doctor if you have any risk factors, and seek immediate medical attention if you experience symptoms such as chest pain, shortness of breath, or leg swelling.
Blood Cell Count Monitoring: This medication can cause a significant decrease in white and red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding. Regular blood tests are necessary to monitor your cell counts, and your doctor may adjust your dosage accordingly.
Potential for New Cancers: There is a rare risk of developing secondary cancers, such as blood or skin cancers, while taking lenalidomide. Discuss this risk with your healthcare provider.
Liver Damage: Patients with liver issues or those taking other liver-impacting medications should use lenalidomide cautiously. Regular monitoring of liver function tests is advisable.
Severe Skin Reactions: Lenalidomide may cause life-threatening skin reactions, such as Stevens-Johnson syndrome. Discontinue use and seek immediate medical help if you develop fever, blisters, or peeling skin.
Tumor Lysis Syndrome: This rare but serious condition may occur when cancer cells break down rapidly, leading to high levels of uric acid and electrolytes. This can cause kidney damage and heart problems. Monitoring and preventive measures are recommended for those at risk.
Tumor Flare Reaction: Some patients may experience a worsening of their tumor, known as a tumor flare reaction. Inform your doctor if you experience symptoms such as swollen lymph nodes, fever, or rash.
Impaired Stem Cell Mobilization: Lenalidomide can affect stem cell collection for transplantation. Patients eligible for autologous stem cell transplantation should plan collection early in their treatment.
Risk of Death in MCL: In clinical trials for mantle cell lymphoma (MCL), early deaths were more common in patients treated with lenalidomide than those given a placebo. Discuss the potential risks with your healthcare provider if you have MCL.
Consult your healthcare provider before starting lenalidomide, especially if any of these warnings apply to you. In case of an overdose, seek immediate medical assistance.
Revlimid Side Effects
When taking this medication, some common side effects may occur, but they are generally mild. These include diarrhea, a decrease in red blood cells, neutrophils, and platelets, fatigue, back pain, muscle weakness, difficulty sleeping, rash, cough, reduced appetite, shortness of breath, fever, stomach pain, and muscle spasms. If these effects persist or worsen, it is advisable to contact your healthcare provider for guidance.
In addition to the common side effects, some individuals may experience heartburn, joint and muscle pain, pain in the limbs, respiratory infection symptoms, urinary tract infection symptoms like painful urination, headaches, itchy skin, and mood changes such as depression. If you experience these side effects, especially if they become severe, consult your healthcare professional.
There are also rare but serious side effects that require immediate medical attention. These include liver problems characterized by fatigue, loss of appetite, nausea, dark urine, and yellowing of the skin or eyes. Blood clots can also occur, presenting symptoms like weakness, numbness, trouble speaking, dizziness, chest pain, or difficulty breathing. Other severe reactions include serious skin issues like painful blisters or sores, tumor lysis syndrome, and serious infections or bleeding issues. If any of these severe side effects occur, seek urgent medical care.
Is Revlimid considered chemo?
Revlimid (lenalidomide) is not considered traditional chemotherapy. It is classified as an immunomodulatory drug and is used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes. It works by affecting the immune system and inhibiting the growth of cancer cells.
How much does Revlimid cost per month?
The cost of Revlimid can vary significantly based on factors such as dosage, insurance coverage, and pharmacy location. Without insurance, the monthly cost can be several thousand dollars. Patients are encouraged to check with their insurance provider for specific coverage details and to explore patient assistance programs that may be available to help offset costs.
Is Revlimid a high risk medication?
Yes, Revlimid (lenalidomide) is considered a high-risk medication. It has significant potential for serious side effects, including an increased risk of blood clots, birth defects if taken during pregnancy, and other serious health issues. It is important for patients to be closely monitored by their healthcare provider while taking this medication.
Is generic Revlimid cheaper?
Yes, generic versions of Revlimid (lenalidomide) are typically less expensive than the brand-name version. Generic medications usually offer a more affordable option while maintaining the same efficacy and safety profile as their brand-name counterparts. However, prices can vary based on the pharmacy and insurance coverage.
What to avoid while taking Revlimid?
While taking Revlimid, it is important to avoid the following:1. Pregnancy: Revlimid can cause severe birth defects or death to an unborn baby. Women of childbearing potential should use effective contraception and avoid becoming pregnant during treatment.2. Blood Donation: Patients should not donate blood during treatment and for at least 4 weeks after stopping Revlimid, as the drug can be present in the blood and may harm a recipient.3. Breastfeeding: Women should not breastfeed while taking Revlimid, as it is unknown if the drug passes into breast milk and could harm a nursing infant.4. Certain Medications: Avoid taking other medications that may increase the risk of blood clots or interact with Revlimid. Patients should consult their healthcare provider for a complete list of potential drug interactions.5. Driving or Operating Machinery: If experiencing dizziness or fatigue as side effects, patients should avoid activities that require full alertness.Patients should always follow their healthcare provider's advice and report any unusual symptoms or concerns during treatment.